Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lavigne

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Inorganic Chemistry|January 12, 2001
Blue-luminescent/electroluminescent Zn(II) compounds of 7-azaindole and N-(2-pyridyl)-7-azaindole: Zn(7-azaindole)2(CH3COO)2, Zn(NPA)(CH3COO)2, and Zn(NPA)((S)-(+)-CH3CH2CH(CH3)COO)2 (NPA = N-(2-pyridyl)-7-azaindole)Q Wu, J A Lavigne, Y Tao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 30, 1999
Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatmentJ Chen, Y Li, J A Lavigne, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 26, 2018
Training the Twenty-First Century Cancer EpidemiologistT K Lam, J A Lavigne, X Qadir, et al.
Cellular Immunology|July 10, 1996
The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanismsA Schmidt-Choudhury, G T Furuta, J A Lavigne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer riskJ E Goodman, J A Lavigne, J G Hengstler, et al.
Cancer Research|October 19, 2001
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cellsJ A Lavigne, J E Goodman, T Fonong, et al.
International Archives of Allergy and Immunology|May 1, 1995
Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanismsB K Wershil, G T Furuta, J A Lavigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouseB K Wershil, G T Furuta, J A Lavigne, et al.
Carcinogenesis|September 29, 2001
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer riskJ E Goodman, J A Lavigne, K Wu, et al.
Cancer Research|January 4, 1998
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancerJ A Lavigne, K J Helzlsouer, H Y Huang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Inorganic Chemistry|January 12, 2001
Blue-luminescent/electroluminescent Zn(II) compounds of 7-azaindole and N-(2-pyridyl)-7-azaindole: Zn(7-azaindole)2(CH3COO)2, Zn(NPA)(CH3COO)2, and Zn(NPA)((S)-(+)-CH3CH2CH(CH3)COO)2 (NPA = N-(2-pyridyl)-7-azaindole)Q Wu, J A Lavigne, Y Tao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 30, 1999
Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatmentJ Chen, Y Li, J A Lavigne, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 26, 2018
Training the Twenty-First Century Cancer EpidemiologistT K Lam, J A Lavigne, X Qadir, et al.
Cellular Immunology|July 10, 1996
The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanismsA Schmidt-Choudhury, G T Furuta, J A Lavigne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer riskJ E Goodman, J A Lavigne, J G Hengstler, et al.
Cancer Research|October 19, 2001
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cellsJ A Lavigne, J E Goodman, T Fonong, et al.
International Archives of Allergy and Immunology|May 1, 1995
Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanismsB K Wershil, G T Furuta, J A Lavigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouseB K Wershil, G T Furuta, J A Lavigne, et al.
Carcinogenesis|September 29, 2001
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer riskJ E Goodman, J A Lavigne, K Wu, et al.
Cancer Research|January 4, 1998
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancerJ A Lavigne, K J Helzlsouer, H Y Huang, et al.
Pageof 2